FDA finally pulls preterm birth drug Makena from the market

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Finally Pulls Preterm Birth Drug Makena From the Market FDA withdrawal of Makena from the market comes four years after the drug, granted accelerated approval in 2011, failed a post-marketing study to confirm the drug's benefit. The FDA decision also affects generic versions of the drug. Sponsored Content The Vibe at Vive: A Progress Report on Healthcare Transformation Presented by 98point6 and MedCity News Brad Younggren, 98Point6 chief medical officer, talked about the recent sale of its care delivery division, including a stand-alone virtual clinic, to Transcarent. He also described its new focus on licensing its cloud-based software to health system partners to increase access improve qaliy and lower the cost of care. Watch it here Early Bird Rate Ends TODAY Today is your last chance to purchase your ticket to INVEST 2023 and get the Early Bird Rate - a savings of $400 off the Regular Rate. Register now to ensure your seat to watch and connect with: Ala Stanford, M.D., Regional Director U.S. Dept of Health & Human Services of the Mid-Atlantic; Donnie Aga, M.D., Chief Medical Officer Kelsey-Seybold Clinic UnitedHealthcare; Taha Jangda, Managing Director Ascension Ventures; Feyi Ayodele, CEO & Co-Founder CancerIQ; Shannon Skaggs, President Quantum Health; and many more you don't want to miss. Register Now

Featured News

The Conversation Around Cancer Costs Must Go Beyond Drugs As a primary care physician and cancer survivor, I've seen and experienced the physical and […] Scaling Up IVF: How to Increase ROI and Build a (Re)productive IVF Business By investing in the value chain of IVF with the right AI solutions, investors can solve the access problem growing in the IVF space, help more people build their families, and achieve significant ROI. Op-Ed: CMS Should Fine 30% of Hospitals It has Found to Be Violating Federal Price Transparency Law As a first step to move toward greater hospital price transparency and lower costs, CMS can immediately issue $2 million fines on the 30% of American hospitals it concludes are noncompliant. If CMS takes enforcement seriously, the hospital industry will respond by quickly coming into compliance. Oxos Medical Rakes in $23M for Its 'Radiology Department in a Box' Oxos Medical recently raised $23 million in Series A funding. The company's handheld X-ray devices are meant to replace C-arms, which are the leading medical imaging technology. The devices are portable are require little training to use, which is key considering the massive dearth of radiologists entering the field.

Resources

MedCity Moves Podcast: Recent Hires and Layoffs In this month's episode, we dive into some of the recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Tom Richards, who recently became the new executive vice president of business development at Transcarent after spending more than 35 years at Cigna. Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe